Neocardia, LLC

Calculating rank

USPTO Granted Patents = 5

Forward Citations = 419

Loading Chart...

5 inventors (with patents filed for the assignee):

Anthony J Bradshaw (5 out of 19 patents)

Wayne W Snyder (3 out of 5 patents)

Richard T Thornton (3 out of 16 patents)

4. Richard V Calfee (1 out of 18 patents)

5. Albert E Raizner (1 out of 5 patents)

5 patents: Sort by Forward Citations

1. 5971909 - Combined angioplasty and intravascular radiotherapy method and apparatus (1999-10-26),

2. 5882291 - Device and method for controlling dose rate during intravascular (1999-03-16),

3. 5662580 - Combined angioplasty and intravascular radiotherapy method and apparatus (1997-09-02),

4. 5643171 - Method and apparatus for uniform radiation treatment of vascular lumens (1997-07-01),

5. 5616114 - Intravascular radiotherapy employing a liquid-suspended source (1997-04-01),

Company Overview

Neocardia, LLC is a biotechnology company specializing in the development of innovative cardiovascular therapies. With a focus on precision medicine, we are dedicated to advancing treatments for heart disease through cutting edge research and technology. Our team of experts is committed to improving patient outcomes and quality of life by providing personalized solutions for cardiovascular health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

5 Patents

#845 in Houston, TX

#3,340 in Texas

#51,743 in US

Houston, TX, United States of America

Neocardia, LLC

Forward Citations = 419

5 inventors:

Anthony J Bradshaw (5 out of 19 patents)

Wayne W Snyder (3 out of 5 patents)

Richard T Thornton (3 out of 16 patents)

4. Richard V Calfee (1 out of 18 patents)

5. Albert E Raizner (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neocardia, LLC. Retrieved from https://idiyas.com/company/neocardia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]